|Bid Price||GBX 103.40||Offer Price||GBX 103.80|
|Mid Price||-||Day Change||GBX -0.20 (-0.19%)|
|Price Date||19 Oct 2017||Crown Rating|
|Shares Class||Inc.||Yield||0.95 %|
|Total Expense Ratio||0.00||Fund Size||2,602,497,600.00|
|Launch Date||01/03/1989||Standard Initial Charge (%)||0.00|
|Annual Management Charge (%)||0.75||Sector||IMA UK Equity Income|
|Min Investment (£)||1,000,000.00||Total Expense Ratio (%)||0.00|
|ISIN||GB00B58VQH84||Min TopUp (£)||100,000.00|
The fund aims to provide capital growth. At least 80% of the fund will be invested in shares of Japanese companies. The fund has no bias to any particular industry or size of company. Investment is based on Japan's economic strengths, such as its manufacturing industry (in particular those parts that are demonstrating an ability to exploit newly emerging technology) and on sectors benefiting from structural change in the economy. The fund uses Tokyo-based in-house research to identify and invest in attractively valued companies - those whose share prices appear low relative to long-term profit potential. These opportunities are likely to be found across a broad range of industries and are identified by an intensive programme of in-house company contact and analysis. The fund may also invest in other financial instruments and hold cash on deposit. Derivatives may be used to reduce risk or manage the fund more effectively.
Andrew Rose is the Head of Japanese Equities. He holds a degree in Japanese and Politics. His Investment career commenced in 1981 upon joining Schroders. He moved to Tokyo in 1984, returning to London in 1987 where he was responsible for Japanese equity investments for UK and continental European clients. He was seconded to Schroders Japan office as Senior Investment Officer in 1996. He returned to London in 1999 as Joint Head of the Japanese Equity Team, with overall responsibility for smaller company investment in Japan. Returned to Japan in 2001 where he is Head of the Japan office and Pan Pacific equities. He is the executive Director.